Of the top eleven active US patent holders, only four are American companies. But who gets the best return on their innovation rights is less
Of the top eleven active US patent holders, only four are American companies. But who gets the best return on their innovation rights is less
Most patent holders would agree that licensing patents for revenue has gone from bad to awful — from difficult less than a decade ago, to
A California jury has awarded pharmaceutical drug company Merck $200 million, a fraction of what it had sought, for infringement of two of its patents
While many high-tech patents are suffering from devaluation the value of some pharmaceutical patents is soaring. Merck & Co. won a legal victory over
The Eastern District of Texas (E.D. Tx.) is responsible for almost half of all patent suits filed in 2015, and one judge, Rodney Gilstrap, is
Valencia Martin Wallace, Deputy Commissioner for Patent Quality at the United States Patent and Trademark Office, will deliver the keynote address at the USPTO’s Enhanced
For more than a year a man slept in his SUV parked on the upscale Park Slope section of Brooklyn. The man, call him Gene,
While it may seem like all of the patent infringement targets are large technology companies in 2015, at least 7 of the top 10 defendants
If it seems like US patent transactions have fallen dramatically over past few years you are not imagining things, says a Chicago patent attorney. According
Three public companies that are active in patent licensing or highly dependent on patents for success have been added to the IP CloseUp 30 index
After declining 9% in 2015 from the 2014 fiscal year Patent Trial and Appeal Board-instituted inter partes reviews (IPRs) have leveled off. Instituted reviews were at 74%
Among the most watched areas for new patent value is financial technology, covering inventions in areas like authentication, mobile payments and wealth management. Fintech is